Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
122905313	12290531	3	F	20160314	20160810	20160421	20160816	EXP		FR-PFIZER INC-2016214906	PFIZER		57.00	YR		F	Y	0.00000		20160816		OT	FR	FR

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT
122905313	12290531	1	PS	NEURONTIN	GABAPENTIN	1	Oral	300 MG, DAILY EVENING	Y	20235	300	MG
122905313	12290531	2	SS	NEURONTIN	GABAPENTIN	1	Oral	600 MG, DAILY EVENING	Y	20235	600	MG
122905313	12290531	3	SS	NEURONTIN	GABAPENTIN	1	Oral	900 MG, DAILY EVENING	Y	20235	900	MG

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
122905313	12290531	1	Restless legs syndrome

Outcome of event

Event ID	CASEID	OUTC COD
122905313	12290531	HO

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
122905313	12290531		Product use issue
122905313	12290531		Rash erythematous

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
122905313	12290531	1	20160314	20160314
122905313	12290531	2	20160315	20160315
122905313	12290531	3	20160316	20160316